Long-Term Outcomes of Cardiovascular Operations in Children With Connective Tissue Disorders

Amanda S Thomas1, Erin E Falk2, Sarah Mahoney3

  • 1Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.

Insights

Pediatric cardiac surgery for connective tissue disorders has high long-term cardiovascular mortality. Infantile cases had poor survival, and late deaths in older children highlight the need for lifelong monitoring.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Connective Tissue Disorders

Background:

  • Connective tissue disorders frequently cause cardiovascular complications requiring surgical intervention in children.
  • Understanding long-term outcomes is crucial for managing these complex pediatric patients.

Purpose of the Study:

  • To describe the long-term outcomes of pediatric patients undergoing their first cardiac surgery for connective tissue-related cardiovascular conditions.
  • To identify survival rates and causes of late mortality in this specific patient cohort.

Main Methods:

  • Retrospective analysis of 103 patients (<21 years) from the Pediatric Cardiac Care Consortium (1982-2003).
  • Long-term follow-up through 2019 using National Death Index and Organ Procurement linkage.
  • Analysis focused on aortic and atrioventricular valve surgeries.

Main Results:

  • Most patients (n=85) had aortic site surgery, often with composite grafts (n=50).
  • Among 99 survivors to discharge, 3 infantile patients died before age 4; 29 deaths and 1 transplant occurred in the non-infantile group over a median 19.5-year follow-up.
  • Post-discharge survival for non-infantile patients was 92.2% at 10 years, 68.2% at 20 years, and 56.7% at 25 years.

Conclusions:

  • Cardiovascular pathology was the primary cause of death in both infantile (100%) and non-infantile (89%) patients post-discharge.
  • Significant late mortality underscores the critical need for continuous monitoring and management of pediatric patients with connective tissue disorders undergoing cardiac surgery.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
17
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
501
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37